A new study shows that a shorter, less toxic chemotherapy regimen that includes the drug Herceptin appears to be just as effective in women with HER-2 positive breast cancer as using a standard three-drug therapy with Herceptin, a strategy that can be harder on the heart.
Read more here:
Less Toxic Treatment for Aggressive Breast Cancers?